ER Editor: Please note the source of the report is Associated Press, so we don’t expect any real understanding of vaccines and the vaccine debate to be expressed. Comparing google and duckduckgo, we can definitely recommend the latter for picking up this story. The Daily Mail republished the same AP article, but added a pro-vax piece below it with Dr. Sarah Gilbert, head of the Oxford team whose vaccine is being trialled.
Oxford Vaccine Group at Oxford University has produced a spiked protein vaccine against ‘COVID-19’ and this would appear to be the vaccine that is being tested and protested in the article below. We highly recommend reading Robert F. Kennedy’s recent piece titled Another Gates Vaccine Bites the Dust … Sick Monkeys Everywhere!, which details how all the macaque monkeys used in Oxford’s vaccine trials became sick after being given it, and proceeded to infect others through the process of viral shedding.
The article below resurrects the indelicate yet revealing comments made by a Paris doctor, Dr. Jean-Paul Mira (pictured), head of ICU at the Paris Cochin Hospital, who suggested publicly on television at the beginning of April that studies of the virus be done in Africa because of its lack of masks, treatment and resuscitation. Perhaps this has usefully contributed to some of the activist-inspired backlash taking place against the Oxford vaccine trials going on there.
Protests Mounted Against Africa’s 1st COVID-19 Vaccine Test
Johannesburg, Jul 1 (AP) – Protesters against Africa’s first COVID-19 vaccine trial burned their face masks Wednesday as experts note a worrying level of resistance and misinformation around testing on the continent.
Anti-vaccine sentiment in Africa is “the worst I’ve ever seen,” the CEO of the GAVI vaccine alliance, Seth Berkley, told an African Union vaccine conference last week.
“In general, people in Africa know the diseases and want to protect each other,” he said. “In this case, the rumor mill has been dramatic.” The trial that began last week in Johannesburg is part of one already underway in Britain of the vaccine developed at the University of Oxford. Some 2,000 volunteers in South Africa are expected to take part.
It’s important that vaccines be tested in Africa to see how they perform in the local context, professor of vaccinology Shabir Madhi, leader of the new COVID-19 vaccine trial in South Africa, told reporters and others in a webinar Sunday.
But the small band of demonstrators who gathered Wednesday at the University of the Witwatersrand, where the trial is based, reflect long-running fears among some in Africa over testing drugs on people who don’t understand the risks.
“The people chosen as volunteers for the vaccination, they look as if they’re from poor backgrounds, not qualified enough to understand” protest organizer Phapano Phasha told The Associated Press ahead of the event.
“We believe they are manipulating the vulnerable.” The activist and political commentator brought up the widely circulated remarks earlier this year by a French researcher, Jean-Paul Mira, who said, “”If I can be provocative, shouldn’t we be doing this study in Africa, where there are no masks, no treatments, no resuscitation?” He compared it to some AIDS studies: “In prostitutes, we try things because we know that they are highly exposed and that they do not protect themselves.”
“The narrative we got is our continent is a dumping ground,” Phasha said. First ensure the vaccine works elsewhere before bringing it to Africa, she added.
The French researcher later apologized for his comments, but they continue to circulate on social media among those opposed to vaccine testing in Africa, Meanwhile, anger among African health officials and others was swift. The Ethiopian director of the World Health Organization, Tedros Adhanom Ghebreyesus, called the comments “racist” and a “hangover from a colonial mentality.” The head of the Africa Centers for Disease Control and Prevention, John Nkengasong, called the remarks “very disgusting” and “condescending.”
“Africa CDC will continue to work very closely with the World Health Organization to ensure that only ethically and scientifically sound clinical trials for vaccines and therapies will be conducted in Africa, using exactly the same standards and principles as those employed elsewhere in the world,” Nkengasong said in a statement.
“These principles will be guided by respect for the dignity of Africans, the beneficence and non-maleficence, and justice.” Madhi, the professor in charge of the South Africa vaccine trial, has said volunteers were given an explanation about the trial and possible risks and then had to score 80 per cent on a questionnaire to take part.
But why not target more affluent parts of South African society? Phasha asked. “I believe in science,” she said. “And I believe that science has managed to solve most of the problems society is faced with. I’m not against vaccinations, I’m against profiteering.”
Fellow protesters sang and danced with banners saying “We not guinea pigs” and “No safe vaccine.” “If you want to test, test in the areas which they call the epicenter of the world,” demonstrator Sean Goss said.
It’s not clear when Africa’s first vaccine trial will begin showing results, but a worried Madhi has said the local surge in confirmed cases could mean seeing them months earlier than expected.
South Africa now has more than 151,000 confirmed coronavirus cases, the most on the African continent. Africa overall has more than 400,000 cases. (ER: For relativity, Africa had a population of 1.2 billion in 2016.)
As the pandemic picks up speed in Africa, health officials are urging that any vaccine be distributed equitably around the world. A quarter of all vaccines for other diseases are used in Africa and yet the continent has little production capacity, putting its 1.3 billion people at risk of being near the end of the line for any COVID-19 vaccine.
The new global attention to racial injustice creates a key time to act, the head of the Nigeria Center for Disease Control told the AU vaccine conference last week.
“If we don’t use this moment when, for better or worse, we have the political attention of people, we will regret it,” Chikwe Ihekweazu said.
Africa must play a role in the new vaccine trials, the vice chancellor of the University of Cape Town, Mamokgethi Phakeng, and the chair of South Africa’s Council for Scientific and Industrial Research, Thokozani Majozi, wrote this month in the Sunday Times newspaper.
They, too, brought up the French researcher’s comments and they criticized the calls for an “African-only” approach to finding a vaccine, saying it would pull the continent even further from the global stage. “It would be tragic if Africa chose not to take part, at all levels, in clinical trials of a Covid-19 vaccine – or any medical treatment that could save lives,” they said. (AP)
The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)
Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.
Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.